Cassava Sciences and its Alzheimer’s drug are done. The damage lingers
The Cassava Sciences story ended Monday exactly as many knew it would — with the company’s experimental drug for Alzheimer’s disease, simufilam, failing a clinical trial.
Related Articles
Gap Years—Unbridled Good or Unwarranted Cost?
This Viewpoint discusses the increasing popularity of taking a gap year between college and medical school and raises questions about the perceived necessity of this…
Health Care Utilization With Telemedicine and In-Person Visits in Pediatric Primary Care
This cohort study compares rates of physician prescribing and ordering and downstream health care utilization associated with pediatric primary care telemedicine visits vs in-person visits.
Large Language Model Influence on Diagnostic Reasoning
This randomized clinical trial evaluates the diagnostic performance of physicians with use of a large language model compared with conventional resources.
Transfusion in Acute Brain Injury: Is Less Still More?
Whether a restrictive or liberal transfusion strategy offers the best outcomes after acute brain injury has been the subject of ongoing debate. Will publication of…
Alector Therapeutics’ novel Alzheimer’s strategy fails in Phase 2 trial
Alector Therapeutics, working with AbbVie, was testing whether modulating immune cells in brain would slow Alzheimer’s disease. Its drug failed the Phase 2 trial.
Value-Based Care Is a Four Layer Cake — Why Do We Only Focus on The Icing? – MedCity News
During a recent panel discussion, three healthcare experts discussed reasons why value-based care is struggling to reach scale.
The first-ever Costco with apartments is officially in the works
A new development in South Los Angeles will soon feature the first-ever Costco with apartments.
Inside the race to be crowned North Carolina’s sexiest collard farmer
Reigning champion battles with Meta’s nudity rules in competition where farmers pose with their beloved greens
What is in your LLM-based framework?
Nature Machine Intelligence – To maintain high standards in clarity and reproducibility, authors need to clearly mention and describe the use of GPT-4 and other…
Why whooping cough cases are spiking across the U.S.
Whooping cough cases haven’t been this high at this time of year since 2014, according to the CDC